Jay Hastings is the Chief Executive Officer at PlexusDx, a CLIA-certified laboratory focused on pharmacogenomics and precision medication support. They have been with PlexusDx since 2023 and previously served as CEO at Base10 Genetics, where they led significant mergers and achieved impressive revenue growth. Currently, Hastings is also involved with CANCER FUND as a member of the Screening Committee, supporting early-stage cancer therapies and technologies. They hold a Master of Science in Finance from Northeastern University, earned in 2015.
This person is not in the org chart
This person is not in any teams
This person is not in any offices